The coronavirus vaccine has arrived. The U.K. began the first post-trial injections of the BioNTech/Pfizer vaccine with a 90-year-old woman on Tuesday, with hospital workers not far behind her. (China and Russia have also begun deploying their own vaccines, but it is not clear yet how effective they are.)
The Food and Drug Administration is somewhat behind the U.K. in its approval process for the BioNTech vaccine, but it is expected in the next few days. Though the virus is spreading completely out of control in almost every state, it’s good news on that front at least. Except there’s another problem: The U.S.